| |
Company
Roster
|
|
Total
Insiders : |
7 |
|
|
|
Total
Direct Shares :
|
931,534 |
|
|
Total
Indirect Shares :
|
2,134,327 |
| |
%
Held by Insiders:
|
3.62% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Lorrain Daniel S. |
Chief Scientific Officer |
2026-02-03 |
156,052 |
2026-02-03 |
6,842 |
| Watkins Tim |
CMO & Head of Development |
2026-01-28 |
0 |
2025-12-29 |
0 |
| Huhn Stephen L. |
CMO & Sr VP, Clinical Dev. |
2024-08-13 |
12,800 |
2024-08-13 |
0 |
| Versant Ventures Iv, Llc |
10% Owner |
2024-04-09 |
375,535 |
2024-04-09 |
148,312 |
| Versant Vantage I Gp-Gp, Llc |
|
2024-04-04 |
375,535 |
|
0 |
| Stengone Carmine N. |
Officer, Director |
2024-04-04 |
11,612 |
|
0 |
| Johnson & Johnson Development Corp Et Al |
10% Owner |
|
0 |
2024-04-09 |
1,979,173 |
|
|
0.52 (3.59%) 
